Table 2 Studies utilising routinely collected data in HIV testing and counselling, prevention of mother-to-child transmission (PMTCT) and social behavioural change programmes in Zambia
First author, year of publication | Data collection period | Sample size | Sampled population | Outcomes assessed |
|---|---|---|---|---|
HIV testing and counselling | ||||
Topp et al. [31] | 2008–2011 | 2239 | Adults only | CD4 count, haemoglobin level, BMI, education level, partner’s HIV status |
Topp et al. [32] | 2008–2010 | 44,420 | Adults only | HIV testing, enrolment into care |
Czaicki et al. [33] | 2011–2012 | 10,806 | Adult couples | Cohabitation length, prior HIV testing, current antiretroviral use |
Kankasa et al. [34] | 2006–2007 | 15,670 | Children | HIV testing, testing coverage, HIV counselling, |
PMTCT | ||||
Killam et al. [35] | 2007–2008 | 13,917 | Women initiating ART | Women eligible for ART, women initiating ART |
Stringer et al. [36] | 2001 | 17,263 | Women only | Women tested, mothers and babies receiving NVP |
Stringer et al. [37] | 2003 | 8787 | Mother baby pairs | Gravidity, offered testing, tested, infant given NVP |
Chibwesha et al. [38] | 2007–2010 | 1813 | Mother baby pairs | CD4 count, date of highly active ART initiation, infant HIV status |
Liu et al. [39] | 2007– 2009 | 13,888 | Women initiating ART | CD4 count, haemoglobin level, syphilis, tuberculosis, HIV status |
Chintu et al. [40] | 2004–2006 | 6740 | Women on ART | Mortality, NVP exposure, CD4 count, haemoglobin level |
Mandala et al. [41] | 2007–2008 | 14,815 | Women on ART | CD4 count, initiated on ART |
Torpey et al. [20] | 2005–2008 | 9723 | Women on ART | HIV testing, enrolled to care, received ART |
Chibwesha et al. [42] | 2009–2010 | 18,407 | Women initiating ART | CD4 count, haemoglobin level, use of contraceptives |
Stringer et al. [43] | 2002–2006 | 243,302 | Women and baby pairs | HIV status, number testing positive, attended antenatal care |
Mulindwa [44] | Not stated | 146 | Women initiating ART | NVP toxicity, hepatic toxicity, WHO grading of toxicity |
Ngoma et al. [45] | 2008–2009 | 279 | Women only | HIV-free at 12 months, mortality rates, HIV transmission |
Torpey et al. [46] | 2007–2010 | 28,320 | Children only | HIV testing, type of PMTCT regimen |
Torpey et al. [47] | 2007–2009 | 8237 | Children | HIV testing, type of PMTCT regimen |
Albrecht et al. [48] | 2001–2003 | 760 | Women only | PMTCT drug adherence, partner disclosure |
Social and behavioural change | ||||
Kankasa et al. [34] | 2004–2007 | 27,115 | Adults on ART | Adherence, mortality, loss to follow-up, CD4 count |
Goldman et al. [49] | 2006–2007 | 913 | Adults on ART | Adherence, viral load |
Carlucci et al. [50] | 2006 | 542 | Adults on ART | Drug adherence |
Birbeck et al. [51] | 2005–2006 | 255 | Adults on ART | Drug adherence |